mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 25, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Steven V Ley1, Miles N Tackett, Matthew L Maddess
1Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK. svl1000@cam.ac.uk
Researchers developed a novel, convergent synthesis for rapamycin, a potent immunosuppressant and anti-cancer drug. This new method utilizes macro-etherification and catechol-templating to efficiently construct the complex macrocyclic core.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: